Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Harbour BioMed
Biotech
Amgen loses in Harbour antibody patent case, ordered to pay $20M+
The jury decided that Amgen must pay Harbour $20.2 million in damages, which could be tripled as the infringement is deemed willful.
Angus Liu
Jun 15, 2026 10:34am
Eric Topol boards Flagship as advisor—Chutes & Ladders
Mar 20, 2026 8:30am
Harbour sails with Solstice in $1.1B biobucks deal
Feb 24, 2026 2:38pm
Harbour BioMed docks with BMS in antibody research deal
Dec 17, 2025 8:55am
Otsuka's $670M pact to point Harbour's TCE to autoimmune disease
Jun 23, 2025 6:29am
AstraZeneca details $2.5B investment in China's political center
Mar 21, 2025 8:35am
